X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6292) 6292
Newsletter (163) 163
Magazine Article (36) 36
Newspaper Article (28) 28
Dissertation (12) 12
Book Chapter (11) 11
Conference Proceeding (1) 1
Government Document (1) 1
Publication (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4748) 4748
science & technology (3849) 3849
life sciences & biomedicine (3669) 3669
female (3179) 3179
male (3138) 3138
amoxicillin - administration & dosage (2740) 2740
amoxicillin (2458) 2458
adult (2095) 2095
middle aged (1909) 1909
amoxicillin - therapeutic use (1860) 1860
anti-bacterial agents - administration & dosage (1729) 1729
anti-bacterial agents - therapeutic use (1480) 1480
helicobacter infections - drug therapy (1404) 1404
drug therapy, combination (1337) 1337
aged (1272) 1272
treatment outcome (1243) 1243
antibiotics (1224) 1224
helicobacter pylori (1122) 1122
pharmacology & pharmacy (845) 845
adolescent (827) 827
gastroenterology & hepatology (816) 816
child (793) 793
administration, oral (771) 771
drug administration schedule (766) 766
microbiology (706) 706
animals (694) 694
clarithromycin - administration & dosage (678) 678
child, preschool (675) 675
helicobacter pylori - drug effects (645) 645
prospective studies (622) 622
amoxicillin - adverse effects (620) 620
metronidazole - administration & dosage (586) 586
infectious diseases (585) 585
abridged index medicus (573) 573
omeprazole - administration & dosage (552) 552
infant (513) 513
time factors (494) 494
anti-bacterial agents - adverse effects (488) 488
penicillins - administration & dosage (485) 485
health aspects (472) 472
anti-ulcer agents - administration & dosage (458) 458
drug therapy (456) 456
amoxicillin - pharmacology (444) 444
amoxicillin-potassium clavulanate combination - administration & dosage (438) 438
microbial sensitivity tests (429) 429
dosage and administration (420) 420
anti-bacterial agents - pharmacology (415) 415
amoxicillin-potassium clavulanate combination - therapeutic use (414) 414
clarithromycin - therapeutic use (410) 410
care and treatment (397) 397
follow-up studies (393) 393
pediatrics (391) 391
acute disease (387) 387
dentistry (387) 387
double-blind method (384) 384
metronidazole - therapeutic use (382) 382
general & internal medicine (381) 381
research (373) 373
drug therapy, combination - therapeutic use (361) 361
medicine, general & internal (361) 361
penicillins - therapeutic use (358) 358
analysis (342) 342
infections (341) 341
aged, 80 and over (336) 336
clavulanic acid (330) 330
anti-ulcer agents - therapeutic use (323) 323
risk factors (321) 321
helicobacter infections - microbiology (318) 318
drug therapy, combination - administration & dosage (317) 317
drug resistance (310) 310
young adult (308) 308
omeprazole - therapeutic use (301) 301
research article (291) 291
bacteria (290) 290
amoxicillin - pharmacokinetics (287) 287
clarithromycin (287) 287
bacterial infections - drug therapy (285) 285
metronidazole (280) 280
2-pyridinylmethylsulfinylbenzimidazoles (278) 278
immunology (270) 270
drug resistance, bacterial (269) 269
clavulanic acids - administration & dosage (267) 267
omeprazole - analogs & derivatives (265) 265
lansoprazole (263) 263
helicobacter pylori - isolation & purification (259) 259
helicobacter infections (258) 258
dentistry, oral surgery & medicine (256) 256
penicillin (254) 254
antimicrobial agents (253) 253
clinical trials (253) 253
drugs (250) 250
dose-response relationship, drug (246) 246
amoxicillin-potassium clavulanate combination (244) 244
children (244) 244
drug resistance in microorganisms (230) 230
otitis media - drug therapy (230) 230
internal medicine (228) 228
retrospective studies (227) 227
helicobacter infections - complications (224) 224
recurrence (223) 223
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5885) 5885
Japanese (205) 205
French (188) 188
German (137) 137
Spanish (102) 102
Russian (59) 59
Italian (55) 55
Portuguese (25) 25
Chinese (24) 24
Polish (20) 20
Dutch (15) 15
Korean (10) 10
Bulgarian (9) 9
Czech (8) 8
Hungarian (5) 5
Swedish (5) 5
Hebrew (4) 4
Norwegian (4) 4
Romanian (4) 4
Slovak (4) 4
Turkish (4) 4
Croatian (3) 3
Danish (3) 3
Bosnian (2) 2
Afrikaans (1) 1
Finnish (1) 1
Serbian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 07/2016, Volume 151, Issue 1, pp. 51 - 69.e14
Journal Article
European journal of internal medicine, ISSN 0953-6205, 07/2016, Volume 32, pp. 84 - 90
Abstract Background Currently only a few studies compare sequential and concomitant non-bismuth Helicobacter pylori therapies referring to high antibiotic... 
Internal Medicine | H. pylori treatment | Sequential treatment | First line | Concomitant treatment | Metronidazole resistance | Clarithromycin resistance | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Esomeprazole - administration & dosage | Humans | Middle Aged | Carbon Isotopes | Drug Resistance, Bacterial | Male | Helicobacter Infections - pathology | Helicobacter pylori | Peptic Ulcer - microbiology | Proton Pump Inhibitors - administration & dosage | Helicobacter Infections - drug therapy | Clarithromycin - administration & dosage | Adult | Female | Helicobacter Infections - metabolism | Urea - metabolism | Amoxicillin - administration & dosage | Drug Therapy, Combination | Dyspepsia - drug therapy | Metronidazole - administration & dosage | Breath Tests | Dyspepsia - microbiology | Pyloric Antrum - pathology | Biopsy | Aged | Anti-Bacterial Agents - administration & dosage | Peptic Ulcer - drug therapy | Clinical trials | Drug resistance in microorganisms | Clarithromycin | Index Medicus | Helicobacter Infections/drug therapy | Peptic Ulcer/drug therapy | Proton Pump Inhibitors/administration & dosage | Helicobacter Infections/pathology | Peptic Ulcer/microbiology | Tissues and Organs | Life Sciences | Esomeprazole/administration & dosage | Hépatology and Gastroenterology | Pyloric Antrum/pathology | Anti-Bacterial Agents/administration & dosage | Dyspepsia/microbiology | Helicobacter Infections/metabolism | Bacteriology | Clarithromycin/administration & dosage | Urea/metabolism | Metronidazole/administration & dosage | Microbiology and Parasitology | Human health and pathology | Amoxicillin/administration & dosage | Dyspepsia/drug therapy
Journal Article
Gut, ISSN 0017-5749, 09/2016, Volume 65, Issue 9, pp. 1439 - 1446
ObjectiveThe objective of this study was to assess the efficacy, safety and tolerability of vonoprazan, a novel potassium-competitive acid blocker, as a... 
antibiotic therapy | clinical trials | Helicobacter pylori infection | helicobacter pylori - treatment | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Humans | Middle Aged | Helicobacter Infections - complications | Helicobacter pylori - drug effects | Male | Drug Monitoring - methods | Proton Pump Inhibitors - administration & dosage | Pyrroles - administration & dosage | Helicobacter Infections - drug therapy | Clarithromycin - administration & dosage | Metronidazole - adverse effects | Peptic Ulcer - diagnosis | Pyrroles - adverse effects | Adult | Female | Amoxicillin - administration & dosage | Anti-Bacterial Agents - adverse effects | Helicobacter Infections - diagnosis | Lansoprazole - administration & dosage | Proton Pump Inhibitors - adverse effects | Double-Blind Method | Drug Administration Schedule | Clarithromycin - adverse effects | Metronidazole - administration & dosage | Treatment Outcome | Drug Therapy, Combination - methods | Lansoprazole - adverse effects | Sulfonamides - adverse effects | Amoxicillin - adverse effects | Helicobacter pylori - isolation & purification | Anti-Bacterial Agents - administration & dosage | Peptic Ulcer - drug therapy | Breath Tests - methods | Peptic Ulcer - etiology | Sulfonamides - administration & dosage | Usage | Safety and security measures | Research | Helicobacter pylori | Antacids | Index Medicus | Abridged Index Medicus | Helicobacter Pylori | HELICOBACTER PYLORI - TREATMENT | CLINICAL TRIALS | 1506 | ANTIBIOTIC THERAPY | HELICOBACTER PYLORI INFECTION
Journal Article
The Lancet (British edition), ISSN 0140-6736, 11/2016, Volume 388, Issue 10058, pp. 2355 - 2365
Summary Background Whether concomitant therapy is superior to bismuth quadruple therapy or 14-day triple therapy for the first-line treatment of Helicobacter... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Humans | Middle Aged | Helicobacter pylori - drug effects | Male | Antacids - therapeutic use | Anti-Bacterial Agents - therapeutic use | Proton Pump Inhibitors - administration & dosage | Metronidazole - therapeutic use | Helicobacter Infections - drug therapy | Clarithromycin - administration & dosage | Organometallic Compounds - therapeutic use | Female | Urea - metabolism | Amoxicillin - administration & dosage | Lansoprazole - administration & dosage | Drug Administration Schedule | Metronidazole - administration & dosage | Breath Tests | Tetracycline - therapeutic use | Clarithromycin - therapeutic use | Proton Pump Inhibitors - therapeutic use | Amoxicillin - therapeutic use | Taiwan | Drug Therapy, Combination - statistics & numerical data | Lansoprazole - therapeutic use | Antacids - administration & dosage | Anti-Bacterial Agents - administration & dosage | Tetracycline - administration & dosage | Organometallic Compounds - administration & dosage | Clinical trials | Medical colleges | Helicobacter infections | Care and treatment | Helicobacter pylori | Antiulcer drugs | Analysis | Bacteria | Bacterial infections | Antibiotics | Drug resistance | Drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 377, Issue 9769, pp. 905 - 913
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 381, Issue 9862, pp. 205 - 213
Journal Article